BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31405342)

  • 1. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.
    Hadj-Ahmed M; Ghali RM; Bouaziz H; Habel A; Stayoussef M; Ayedi M; Hachiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
    Tumour Biol; 2019 Aug; 41(8):1010428319869096. PubMed ID: 31405342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
    Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in TGFB1 gene and risk of idiopathic recurrent pregnancy loss.
    Magdoud K; Granados Herbepin V; Messaoudi S; Hizem S; Bouafia N; Almawi WY; Mahjoub T; Touraine R
    Mol Hum Reprod; 2013 Jul; 19(7):438-43. PubMed ID: 23416372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Transforming Growth Factor β1 Gene Polymorphisms and Inflammatory Factor Levels with Susceptibility to Sepsis.
    Zheng R; Fu Z; Zhao Z
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):187-198. PubMed ID: 33734893
    [No Abstract]   [Full Text] [Related]  

  • 5. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women.
    Habel AF; Ghali RM; Bouaziz H; Daldoul A; Hadj-Ahmed M; Mokrani A; Zaied S; Hechiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
    Tumour Biol; 2019 Apr; 41(4):1010428319845749. PubMed ID: 31014197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.
    Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV
    J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of 5 Well-Defined Polymorphisms in the Gene Encoding Transforming Growth Factor-β1 With Coronary Artery Disease Among Chinese Patients With Hypertension.
    Xu J; Yu X; Huang C; Qin R; Peng F; Lin J; Niu W
    Angiology; 2015 Aug; 66(7):652-8. PubMed ID: 25155040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TGFB1 polymorphism in the development of metastatic brain tumors in non-small cell lung cancer patients.
    Wang HB; Song WG; Liu HQ; Fang F; Xiao Y
    Genet Mol Res; 2015 Apr; 14(2):3545-50. PubMed ID: 25966122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
    Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ;
    Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity.
    Zhou YT; Zheng LY; Wang YJ; Yang L; Xie YT; Panda I; Tian XX; Fang WG
    Breast Cancer Res Treat; 2020 Nov; 184(1):237-248. PubMed ID: 32757134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 is a novel susceptibility gene for adolescent idiopathic scoliosis.
    Ryzhkov II; Borzilov EE; Churnosov MI; Ataman AV; Dedkov AA; Polonikov AV
    Spine (Phila Pa 1976); 2013 May; 38(12):E699-704. PubMed ID: 23446766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 (TGFβ1) polymorphisms and unexplained infertility: A genetic association study.
    Marhemati F; Rezaei R; Mohseni Meybodi A; Taheripanah R; Mostafaei S; Amani D
    Syst Biol Reprod Med; 2020 Aug; 66(4):267-280. PubMed ID: 32735465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients' characteristics and TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Oda JMM; Hirata BKB; de Oliveira CEC; Campos CZ; de Oliveira KB; Guembarovski RL; Watanabe MAE
    Cytokine; 2020 Mar; 130():155079. PubMed ID: 32229413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study.
    Trugilo KP; Cebinelli GCM; Pereira ÉR; Okuyama NCM; Cezar-Dos-Santos F; Castilha EP; Flauzino T; Hoch VB; Watanabe MAE; Guembarovski RL; de Oliveira KB
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611878
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Stadtlober NP; Flauzino T; Santos LFDRF; Iriyoda TMV; Costa NT; Lozovoy MAB; Reiche EMV; Simão ANC
    Autoimmunity; 2021 Dec; 54(8):569-575. PubMed ID: 34519592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India.
    Raina P; Sikka R; Kaur R; Sokhi J; Matharoo K; Singh V; Bhanwer AJ
    OMICS; 2015 May; 19(5):306-17. PubMed ID: 25871499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease.
    Juarez I; Gutierrez A; Vaquero-Yuste C; Molanes-López EM; López A; Lasa I; Gómez R; Martin-Villa JM
    J Cell Mol Med; 2021 Jan; 25(2):774-783. PubMed ID: 33274798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.